FDA, AstraZeneca prep for oncology adcomm

April 29, 2026 02:32 PM EDT R&DPharmaFDA+ FDA re­vives on­col­o­gy ad­vi­so­ry pan­el to de­bate As­traZeneca drugs Max Bayer Senior Reporter The FDA is set to con­vene its first ad­vi­so­ry meet­ing of on­col­o­gy ex­perts in about nine months, with a cou­ple of As­traZeneca drugs as the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER